National Hospital Organization Kumamoto Medical Center

Chuo-ku, Kumamoto 860-0008

0 studies enrolling now · 1 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas

Studies at this site

• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early